BABruce C. Allen

Bruce C. Allen

*This is an algorithmically generated author record based on publicly available information.

Bruce C. Allen has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lung cancer risk assessment associated with exposure to hexavalent chromium: Results of pooled analysis of three cohorts

    by Bruce C. Allen, Melissa J. Vincent, Loren Lipworth, Julie M. Panko, Mina Suh, Xiaohui Jiang, Michael T. Mumma, Deborah M. Proctor

    Quantitative risk assessments of inhaled hexavalent chromium (CrVI) have primarily relied on studies of two chromate production worker cohorts, involving male workers exposed to high concentrations of airborne CrVI that caused an exposure-dependent increase in lung cancer and elicited severe respiratory irritation. An additional larger cohort of CrVI-exposed aerospace workers, including women, and with lower intensity exposures, was recently updated with a longer follow-up period and reconstructed cumulative exposure estimates. A risk assessment was conducted using a pooled analysis of individual-level dose-response information from three cohorts, including the aerospace workers, to generate lung cancer inhalation unit risk estimates (IURs). IURs are estimates of the upper-bound of lifetime increased cancer risk from continuous inhalation exposure to 1 µg/m3 and are commonly used in quantitative risk assessment. Use of the pooled cohort broadens the range for dose-response analysis due to the comparatively low exposures to CrVI in the aerospace cohort; moreover, sex-specific risks could be expanded with the inclusion of female workers. Standardized logistic regression using person-year-specific weighted cumulative exposures was used to estimate the probability of lung cancer mortality, with varied weighting approaches. The primary model included male workers from all cohorts with a minimum of one year of CrVI exposure; secondary analyses examined the impacts of sex and short-term exposure. The best fit dose-response function was a Michaelis-Menten relationship. The IUR from the primary model was 0.01 (95%CI: 0.006-0.01) per µg/m3. Best estimates of the three IURs from secondary analyses, which removed the respiratory use adjustment factors, included females from the aerospace cohort and added workers with less than one year of exposure from the chromate production cohorts, were relatively consistent with the primary analyses, ranging from 0.008 to 0.03 per µg/m3. Use of this pooled IUR estimate allows for inclusion of a broader dose-response range and reduced uncertainty through use of a larger population, additional years of follow-up, and incorporation of broader geographical and cohort characteristics with improved relevancy to the general population.


  • Open Access

    Lung cancer mortality among aircraft manufacturing workers with long-term, low-level, hexavalent chromium exposure

    by Loren Lipworth, Julie M. Panko, Bruce C. Allen, Michael T. Mumma, Xiaohui Jiang, Melissa J. Vincent, Jennifer L. Bare, Todor Antonijevic, Stephanie N. Vivanco, Donald E. Marano, et al.

    Hexavalent chromium (CrVI) is known to cause lung cancer among workers exposed to high concentrations in certain historical industries. It is also a toxic air contaminant considered to pose a potentially significant cancer risk at comparatively low concentrations in urban air. However, very limited data currently exist to quantify risk at low-concentration occupational or environmental exposures. This study reconstructs individual-level exposures using a job-exposure matrix (JEM) and examines mortality among 3,723 CrVI-exposed aircraft manufacturing workers, including 440 women with long-term low-level CrVI exposures and long-term follow-up. The JEM used Bayesian methods with industrial hygiene data to calculate cumulative worker exposures from 1960 to 1998. A retrospective cohort mortality study was also conducted to calculate standardized mortality ratios (SMRs) by population demographics and to conduct an internally referenced dose-response analysis. CrVI-exposed painters, electroplaters, and aircraft assembly workers, with 1 to 37 years of exposure (median: 8 years) had mean and median cumulative exposures of 16 µg/m3-yrs and 2.9 µg/m3-yrs, respectively. Based on 1,758 observed deaths, mortality from cancer overall (SMR 1.24; 95% CI 1.13-1.36), smoking-related cancers (SMR 1.31; 95% CI 1.15-1.49), and lung cancer (SMR 1.39; 95% CI 1.17-1.63) were significantly elevated and more highly elevated among women (lung cancer SMR 2.61; 95% CI:1.66-3.92). Internal analyses revealed no dose-response relationship between cumulative exposure and lung cancer mortality. Data available for 12% of CrVI-exposed workers showed smoking prevalence higher than general population norms, especially for women. The absence of a dose-response relationship with cumulative exposure suggests that elevated cancer risks are primarily smoking-related in this cohort, and possibly as a consequence, any increased risk associated with CrVI exposure is not observable. Although an association between lung cancer risk and CrVI exposure was not found, this study provides significant new observations in the low exposure range, and among women, which may be useful for quantitative risk assessment.


  • Open Access

    Bayesian hierarchical evaluation of dose-response for peanut allergy in clinical trial screening

    by Lynne T. Haber, John F. Reichard, Alice K. Henning, Peter Dawson, R. Sharon Chinthrajah, Sayantani B. Sindher, Andrew Long, Melissa J. Vincent, Kari C. Nadeau, Bruce C. Allen


  • Open Access

    Bayesian hierarchical dose-response meta-analysis of epidemiological studies: Modeling and target population prediction methods

    by Bruce Allen, Kan Shao, Kevin Hobbie, William Mendez, Janice S. Lee, Ila Cote, Ingrid Druwe, Jeffrey S. Gift, J. Allen Davis


  • Meta-regression analysis of the effects of dietary cholesterol intake on LDL and HDL cholesterol

    by Melissa J Vincent, Bruce Allen, Orsolya M Palacios, Lynne T Haber, Kevin C Maki

    Elevated low-density lipoprotein (LDL) cholesterol is a major risk factor for cardiovascular disease. Dietary guidance recommends reducing saturated fatty acid, trans fatty acid, and cholesterol intakes to reduce circulating LDL cholesterol. Cholesterol intake may also affect high-density lipoprotein (HDL)-cholesterol concentrations, but its impact has not been fully quantified. The aims of this study were to investigate the dose-response relation between changes in dietary cholesterol intake and changes in lipoprotein-cholesterol markers for cardiovascular disease risk and to provide a reference for clinicians on how changes in dietary cholesterol intake affect circulating cholesterol concentrations, after accounting for intakes of fatty acids. We used a Bayesian approach to meta-regression analysis, which uses Markov chain Monte Carlo techniques, to assess the relation between the change in dietary cholesterol (adjusted for dietary fatty acids) and changes in LDL and HDL cholesterol based on the use of data from randomized dietary intervention trials. Fifty-five studies (2652 subjects) were included in the analysis. The nonlinear Michaelis-Menten (MM) and Hill models best described the data across the full spectrum of dietary cholesterol changes studied (0-1500 mg/d). Mean predicted changes in LDL cholesterol for an increase of 100 mg dietary cholesterol/d were 1.90, 4.46, and 4.58 mg/dL for the linear, nonlinear MM, and Hill models, respectively. The change in dietary cholesterol was positively associated with the change in LDL-cholesterol concentration. The linear and MM models indicate that the change in dietary cholesterol is modestly inversely related to the change in circulating HDL-cholesterol concentrations in men but is positively related in women. The clinical implications of HDL-cholesterol changes associated with dietary cholesterol remain uncertain.


  • Dose and temporal evaluation of ethylene oxide-induced mutagenicity in the lungs of male big blue mice following inhalation exposure to carcinogenic concentrations

    by Mugimane G. Manjanatha, Sharon D. Shelton, Ying Chen, Barbara L. Parsons, Meagan B. Myers, Karen L. McKim, B. Bhaskar Gollapudi, Nigel P. Moore, Lynne T. Haber, Bruce Allen, et al.

    Ethylene oxide (EO) is a direct acting alkylating agent; in vitro and in vivo studies indicate that it is both a mutagen and a carcinogen. However, it remains unclear whether the mode of action (MOA) for cancer for EO is a mutagenic MOA, specifically via point mutation. To investigate the MOA for EO‐induced mouse lung tumors, male Big Blue (BB) B6C3F1 mice (10/group) were exposed to EO by inhalation, 6 hr/day, 5 days/week for 4 (0, 10, 50, 100, or 200 ppm EO), 8, or 12 weeks (0, 100, or 200 ppm EO). Lung DNA samples were analyzed for cII mutant frequency (MF) at 4, 8 and 12 weeks of exposure; the mutation spectrum was analyzed for mutants from control and 200 ppm EO treatments. Although EO‐induced cII MFs were 1.5‐ to 2.7‐fold higher than the concurrent controls at 4 weeks, statistically significant increases in the cII MF were found only after 8 and 12 weeks of exposure and only at 200 ppm EO (P ≤ 0.05), which is twice the highest concentration used in the cancer bioassay. Consistent with the positive response, DNA sequencing of cII mutants showed a significant shift in the mutational spectra between control and 200 ppm EO following 8 and 12 week exposures (P ≤ 0.035), but not at 4 weeks. Thus, EO mutagenic activity in vivo was relatively weak and required higher than tumorigenic concentrations and longer than 4 weeks exposure durations. These data do not follow the classical patterns for a MOA mediated by point mutations. Environ. Mol. Mutagen. 58:122–134, 2017.


  • Open Access

    Meta-regression analysis of the effect of trans fatty acids on low-density lipoprotein cholesterol

    by Bruce C. Allen, Melissa J. Vincent, DeAnn Liska, Lynne T. Haber


  • Development and Validation of a Scale to Assess Attitudes and Beliefs About Menthol Cigarettes Among African American Smokers

    by Bruce Allen, Tess Boley Cruz, Earl Leonard, Jennifer B. Unger

    To develop more effective smoking cessation interventions for the 70% of African American smokers who smoke menthol cigarettes, it is important to understand smokers’ reasons for choosing menthols verses nonmenthols. This study conducted a focus group of African American smokers about their attitudes and beliefs about menthol cigarettes. These attitudes and beliefs, along with others from the literature, were included in a survey of 720 African American smokers in Los Angeles County, California. Five common factors emerged—Medicinal Effects, Image, Less Harmful, Tradition, and Taste/Sensation. Menthol smokers had significantly higher scores on the Taste/Sensation, Medicinal Effects, and Less Harmful scales than nonmenthol smokers did. Men were significantly more likely than women to endorse Medicinal Effects, Image, and Tradition, whereas women were significantly more likely to endorse Taste/Sensation. Education was inversely associated with endorsement of Medicinal Effects, Image, Less Harmful, and Tradition. Respondents aged 40 years or older had significantly higher scores on Medicinal Effects, Image, and Less Harmful, compared with younger respondents. Smoking cessation interventions for African American menthol smokers should address commonly held myths that menthols have medicinal effects and are less harmful than nonmenthols, especially among smokers who are older, male, and/or have low levels of education. The new measures presented in this article could be useful for tailoring cessation interventions to individual smokers’ attitudes and beliefs about menthol cigarettes.